Publication for HOXB2 and HOXB4
Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
---|---|---|---|---|---|---|
hsa | HOXB2 | homeobox B2 | 3212 | [link] | ||
hsa | HOXB4 | homeobox B4 | 3214 |
Pubmed ID | Priority | Text |
---|---|---|
21731684 | 0.98 | HOXB4, HOXB5, and HOXB2 genes transformed them into hematopoietic cells. |
0.97 | HOXB4 or HOXB5, but not HOXB2, induced CD45 expression. | |
0.96 | HoxB2, transfection with HoxB4 and HoxB5 induced CD45 expression in 15.5% and 17.9% of cells, respectively. | |
0.94 | HOXB2, HOXB4, and HOXB5 formed hematopoietic colonies when grown in the CFU-GEMM colony culture assay. | |
0.91 | HOXB4 or HOXB5, transfection of MSCs with the HOXB2 gene did not significantly increase but rather enhanced CD45 expression induced by HOXB4 and HOXB5. | |
0.90 | HOXB4 and HOXB5, but not HOXB2, genes following treatment of HS-5 cells with Aza plus GF. | |
0.84 | HOXB2 induced CD45 expression in only 3.7% of the cells, whereas HOXB4 and HOXB5 constitutively induced CD45 expression in 15.5% and 17.9% of the cells, respectively. | |
0.70 | HoxB2, HoxB4 and HoxB5 genes alters skin fibroblast gene expression. | |
0.66 | HOXB2 with HOXB4, or HOXB2 with HOXB4 and HOXB5, both increased the percentage of cells expressing CD45. | |
0.65 | HOXB2, HOXB4, and HOXB5 altered HS-5 cells. | |
27010239 | 0.98 | Hoxb2, Hoxb4, Cebpa, Cebpe and PU.1 in GFP+LSK cells. |
0.97 | Hoxb2, Hoxb4, Cebpa, Cebpe and PU.1 in GFP+LSK cells measured by qPCR. | |
0.93 | Hoxb2 and Hoxb4 promoter-associated CpG islands in WT-transduced cells and hypo-methylation of Hoxb2 in R882H-transduced cells relative to EV-transduced control cells, which was compatible to anterior Hoxb cluster genes expression profile of R882 mutant-transduced stem/progenitor cells (Fig. 2b). | |
0.63 | Hoxb2 and Hoxb4 were upregulated, and Cebpa, Cebpe and PU.1 were downregulated in R882 mutant-transduced LSK cells (Fig. 2a). | |
23630576 | 0.97 | HOXB2, HOXB4 and HOXB7), three genes contain homeodomain (DLX1, LHX4, and VAX2) and two of them belong to HIST gene family (HIST1H3I and HIST1H4L). |
0.97 | HOXB2, HOXB4 and HOXB7 together showed the key function in lung cancers. | |
0.84 | HOXB2, HOXB4 and HOXB7) overlapped with the 40 HOXB2 correlated genes. | |
28697800 | 0.97 | HOXB2, HOXB3, HOXB4, HOXB5, HOXB6, HOXB7, HOXB8: , p-value = 7.94e-62). |
29443048 | 0.97 | HoxB2, HoxA4, HoxB4, HoxB6) markers is not detectable (Figure 3K). |
23650565 | 0.96 | HOXB2, HOXB4, HOXB5, HOXB9, and HOXA5). |
24947980 | 0.96 | HOXB2, HOXB3, HOXB4, HOXB5, HOXB6, HOXB7, HOXB8, HOXB9, and HOXB13:all located in the 17q21 region) was also determined in both the PBT and SLN metastasis analyzed. |
28186679 | 0.96 | HOXB2, and HOXB4 and suppressed HOXB1. |
29137433 | 0.96 | HOXB2, HOXB4, HOXC10, and HOXD13 has been found in cervical cancer cell lines. |
31489945 | 0.96 | HOXB2, and HOXB4, the expression of OTX2 and EN1 as fore-/mid-brain markers was observed only in iNSCs (Figure 3A). |
16895450 | 0.95 | HOXB2, HOXB4, HOXB5, HOXB6, HOXB7, and HOXB9) was limited to the trunk and nondermal samples, whereas HOXD4 and HOXD8 were expressed exclusively in the trunk and proximal leg samples. |
24608967 | 0.94 | HOXB2 (-3.4 fold), HOXB4 (-4.2 fold), HOXB5 (-4.1 fold) and HOXB7 (-4.2 fold), and upregulation of HOXC6 (6.8 fold) and HOXC8 (38.2 fold). |
26655496 | 0.94 | HOXB2, HOXB3 and HOXB4) (Fig. 1c). |
22976993 | 0.92 | Hoxb2 and Hoxb4, Alx-4, AP2 alpha, and Msx1 and Msx2. |
25539595 | 0.92 | HOXB (HOXB2 and HOXB4) genes gradually decreased during myeloid maturation (Figure 1A and Additional file 2: Figure S1). |
30150715 | 0.92 | HOXB2, HOXB4, HOXB6, HOXB8 and HOXC9 in day 10 aggregates under conditions (i-iv). |
31681594 | 0.92 | HOXB2 (P = 0.0026), HOXB3 (P < 0.0001), HOXB4 (P < 0.0001), HOXB6 (P < 0.0001), MEIS1 (P = 0.0001), and PRDM16 (P = 0.0002) genes were all expressed at higher levels compared with high miR-340 expression group. |
18317880 | 0.91 | HOXB2 or HOXB4 in T-lymphocytes was previously shown to block the proliferation of activated cells (Care et al. 1995). |
27052693 | 0.91 | HOXB2, HOXB4 and HOXA10, which provides a new research direction for ATRA in the treatment of leukemia. |
23583175 | 0.90 | HoxB2 and HoxB4 could however be established from precursors treated with RA during the early stages of differentiation (Figure S6). |
25875616 | 0.90 | Hoxb2 and Hoxb4 in the R1-R4 rhombomeres of zebrafish, which has major consequences on the cranial nerves formation and neural crest cells (branchial arch 1) migration and differentiation. |
28213969 | 0.89 | HOXB2, HOXB4, HOXB6, and HOXC1 (Fig. 3E). |
0.56 | HOXB2, HOXB4, HOXB6, and HOXC1 profile indicative for spinal cord cells with a rostral cervical identity 15, 25. | |
18668134 | 0.88 | HOXB2, HOXB3, HOXB4 and MEIS1. |
31266935 | 0.78 | HOXB2/B3/B4, although this difference was statistically significant only for HOXB4. |
0.71 | HOXB4 alone was also significant (Fig. 6c), while HOXB2 and HOXB3 were not significant (Fig. 6d, e). | |
19282867 | 0.76 | HoxB2, HoxB4, HoxB6) during ESC neuralization with our protocol. |
31426381 | 0.68 | HOXB2, HOXB3, HOXB4, LOC404266, HOXB6, NKX2-3, PBX3, C10orf140, LOC100271722, LOC100289444, MEIS1, CPNE8, LOC400931, SDSL, EMR1, and HOXB7. |
26397705 | 0.62 | HOXB2, HOXB3, HOXB4 and MEIS1. |
30154863 | 0.60 | HOXB2, HOXB4, HOXB9, and HOXC9 (but not HOXA9) in primary AML cases is significantly correlated with survival. |
26517675 | 0.56 | HOXB2 (P = 5.95 x 10-8), HOXB3 (P = 5.61 x 10-5), HOXB4 (P = 1.37 x 10-6), HOXB5 (P = 3.90 x 10-6), HOXB6 (P = 2.65 x 10-3), HOXB7 (P = 2.21 x 10-3), HOXB8 (P = 1.78 x 10-2), MEIS1 (P = 6.18 x 10-7), and PBX3 (P = 5.02 x 10-4). |
The preparation time of this page was 0.0 [sec].